MétaCan
Menu
← Back to cohort

Protective Roles of O‐GlcNAc in Neurodegenerative Diseases

2021· article· en· W3167307886 on OpenAlexafffund
David J. Vocadlo

Bibliographic record

VenueThe FASEB Journal · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGlycosylation and Glycoproteins Research
Canadian institutionsSimon Fraser University
FundersAlzheimer Society
KeywordsNeurodegenerationBiochemistryOxidative stressGlycosyltransferaseGenetically modified mouseCytosolGlycationEnzymeGlycobiologyBiologyTransgeneChemistryCell biologyDiseaseGeneMedicineInternal medicineGlycoproteinReceptorGlycan

Abstract

fetched live from OpenAlex

O‐linked N‐acetylglucosamine (O‐GlcNAc) is an abundant form of protein O‐glycosylation found in the nucleus, cytoplasm, and mitochondria of all multicellular eukaryotes. This modification is found on several hundred proteins but is surprisingly regulated by only two enzymes; the glycosyltransferase O‐GlcNAc transferase (OGT) and the glycoside hydrolase O‐GlcNAcase (OGA). Because the substrate of OGT is derived from glucose, the levels of O‐GlcNAc within cells reflect environmental glucose availability. O‐GlcNAc has also emerged as part of a coordinated response to cellular stresses and levels of this modification increase markedly on exposure to diverse stresses ranging from heat shock to oxidative stress. These observations have stimulated interest in the potential protective roles of increased O‐GlcNAc in a range of tissues including in brain, where impaired nutrient utilization has been linked to various neurodegenerative diseases. Remarkably, brain permeable small molecule inhibitors of OGA have been shown to be surprisingly well tolerated in a range of animal models. Moreover, pharmacological agents that increase O‐GlcNAc levels in the brains of various transgenic models of Alzheimer Disease (AD) strikingly reduce the progression of disease pathology and neurodegeneration. While these effects have been shown to be remarkably reproducible, and OGA inhibitors have now been found to be generally well tolerated in early clinical trials, the mechanisms by which O‐GlcNAc protect against these pathologies and neurodegeneration remain less clear. Here we will discuss new advances in the biochemistry of OGA inhibitors, efforts to create improved inhibitors, and the protective effects of OGA in transgenic models of neurodegenerative diseases. Finally, we will discuss recent progress on various possible protective mechanisms by which increased O‐GlcNAc levels confer protection against various neurodegenerative diseases ranging from blockade of aggregation of toxic proteins to the induction of autophagy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.272
Teacher spread0.259 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueThe FASEB Journal→Same topicGlycosylation and Glycoproteins Research→French-language works237,207→